BARIcitinib Cognitive Emotional and Neural signaTuRE
Clinical trial NCT05238896 · TERMINATED
Trial details
- NCT number
- NCT05238896
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-27
- Primary completion
- 2023-02-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.